FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945083001> ?p ?o ?g. }

• W2945083001 endingPage "814" @default.
• W2945083001 startingPage "806" @default.
• W2945083001 abstract "Objectives: The aim of this study was to assess the Dutch nationwide incidence of myelin oligodendrocyte glycoprotein (MOG)-IgG-associated acquired demyelinating syndromes (ADS) and to describe the clinical and serological characteristics of these patients. Methods: All serum samples for routine diagnostics from February 2014 to December 2017 were sent to the single central reference laboratory for the full-length MOG-IgG cell-based assay (CBA) in the Netherlands. Clinical data from patients known in our National ADS centre were available. Results: A total of 1414 samples of 1277 patients were received; of these, 92 patients (7%) were MOG-IgG-seropositive. The mean incidence was 0.16/100,000 people, with higher seropositivity in children (0.31/100,000) than in adults (0.13/100,000). In MOG-IgG-positive patients at the National ADS centre (61/92, 66%), the most common presenting phenotype is acute disseminated encephalomyelitis (ADEM, 56%) in children and optic neuritis (ON, 44%) in adults. Relapsing disease occurred in 9/34 (26%) children and 11/27 (41%) adults during median follow-up of 27.5 months. Patients were tested MOG-IgG-positive >200 months after the initial attack, suggesting an extended time to first relapse (TTFR). Longitudinal analysis of MOG-IgG (25/61, 41%) showed that 67% of the monophasic patients remain seropositive and 60% in relapsing patients. Majority of seronegative patients had no relapses (89%). Conclusion: This nationwide study shows that the overall incidence of MOG-IgG-seropositive disorders is 0.16 per 100,000 people. The distribution over the clinical phenotypes differs between adults and children. Seropositivity can be maintained over years even without clinical activity, while seronegative patients generally had no relapses." @default.
• W2945083001 created "2019-05-29" @default.
• W2945083001 creator A5002486958 @default.
• W2945083001 creator A5006831631 @default.
• W2945083001 creator A5017552910 @default.
• W2945083001 creator A5027802263 @default.
• W2945083001 creator A5047553266 @default.
• W2945083001 creator A5053083847 @default.
• W2945083001 creator A5067419714 @default.
• W2945083001 creator A5072385860 @default.
• W2945083001 date "2019-05-16" @default.
• W2945083001 modified "2023-10-11" @default.
• W2945083001 title "The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults" @default.
• W2945083001 cites W2007502293 @default.
• W2945083001 cites W2059045887 @default.
• W2945083001 cites W2083485745 @default.
• W2945083001 cites W2103812851 @default.
• W2945083001 cites W2111027878 @default.
• W2945083001 cites W2116294933 @default.
• W2945083001 cites W2129229339 @default.
• W2945083001 cites W2155789219 @default.
• W2945083001 cites W2177942776 @default.
• W2945083001 cites W2321839851 @default.
• W2945083001 cites W2342230608 @default.
• W2945083001 cites W2462819126 @default.
• W2945083001 cites W2542372902 @default.
• W2945083001 cites W2548784535 @default.
• W2945083001 cites W2578761578 @default.
• W2945083001 cites W2598701066 @default.
• W2945083001 cites W2728455811 @default.
• W2945083001 cites W2739773649 @default.
• W2945083001 cites W2768094726 @default.
• W2945083001 cites W2770558705 @default.
• W2945083001 cites W2782439756 @default.
• W2945083001 cites W2786802845 @default.
• W2945083001 cites W2791030344 @default.
• W2945083001 cites W2791079491 @default.
• W2945083001 cites W2791164819 @default.
• W2945083001 cites W2800192720 @default.
• W2945083001 doi "https://doi.org/10.1177/1352458519845112" @default.
• W2945083001 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7294530" @default.
• W2945083001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31094288" @default.
• W2945083001 hasPublicationYear "2019" @default.
• W2945083001 type Work @default.
• W2945083001 sameAs 2945083001 @default.
• W2945083001 citedByCount "118" @default.
• W2945083001 countsByYear W29450830012019 @default.
• W2945083001 countsByYear W29450830012020 @default.
• W2945083001 countsByYear W29450830012021 @default.
• W2945083001 countsByYear W29450830012022 @default.
• W2945083001 countsByYear W29450830012023 @default.
• W2945083001 crossrefType "journal-article" @default.
• W2945083001 hasAuthorship W2945083001A5002486958 @default.
• W2945083001 hasAuthorship W2945083001A5006831631 @default.
• W2945083001 hasAuthorship W2945083001A5017552910 @default.
• W2945083001 hasAuthorship W2945083001A5027802263 @default.
• W2945083001 hasAuthorship W2945083001A5047553266 @default.
• W2945083001 hasAuthorship W2945083001A5053083847 @default.
• W2945083001 hasAuthorship W2945083001A5067419714 @default.
• W2945083001 hasAuthorship W2945083001A5072385860 @default.
• W2945083001 hasBestOaLocation W29450830011 @default.
• W2945083001 hasConcept C120665830 @default.
• W2945083001 hasConcept C121332964 @default.
• W2945083001 hasConcept C126322002 @default.
• W2945083001 hasConcept C159654299 @default.
• W2945083001 hasConcept C187212893 @default.
• W2945083001 hasConcept C203014093 @default.
• W2945083001 hasConcept C2776572573 @default.
• W2945083001 hasConcept C2777899865 @default.
• W2945083001 hasConcept C2778486448 @default.
• W2945083001 hasConcept C2779328510 @default.
• W2945083001 hasConcept C2779357208 @default.
• W2945083001 hasConcept C2780640218 @default.
• W2945083001 hasConcept C2781028063 @default.
• W2945083001 hasConcept C45189115 @default.
• W2945083001 hasConcept C61511704 @default.
• W2945083001 hasConcept C71924100 @default.
• W2945083001 hasConceptScore W2945083001C120665830 @default.
• W2945083001 hasConceptScore W2945083001C121332964 @default.
• W2945083001 hasConceptScore W2945083001C126322002 @default.
• W2945083001 hasConceptScore W2945083001C159654299 @default.
• W2945083001 hasConceptScore W2945083001C187212893 @default.
• W2945083001 hasConceptScore W2945083001C203014093 @default.
• W2945083001 hasConceptScore W2945083001C2776572573 @default.
• W2945083001 hasConceptScore W2945083001C2777899865 @default.
• W2945083001 hasConceptScore W2945083001C2778486448 @default.
• W2945083001 hasConceptScore W2945083001C2779328510 @default.
• W2945083001 hasConceptScore W2945083001C2779357208 @default.
• W2945083001 hasConceptScore W2945083001C2780640218 @default.
• W2945083001 hasConceptScore W2945083001C2781028063 @default.
• W2945083001 hasConceptScore W2945083001C45189115 @default.
• W2945083001 hasConceptScore W2945083001C61511704 @default.
• W2945083001 hasConceptScore W2945083001C71924100 @default.
• W2945083001 hasFunder F4320321646 @default.
• W2945083001 hasIssue "7" @default.
• W2945083001 hasLocation W29450830011 @default.
• W2945083001 hasLocation W29450830012 @default.
• W2945083001 hasLocation W29450830013 @default.

• next